2014;9(7):e102031
Personalized dietary intervention strategies will be a focal point of future research
However, excessive use can lead to side effects such as skin irritation, ochronotic (bluish-black discoloration), and potential carcinogenic risks
Not yet, particularly since GLP-1s are not approved to treat anything beyond diabetes, obesity, and obesity-related health issues
Future studies could investigate an extended clear liquid diet period (perhaps 24 h prior to an EGD procedure, similar to what colonoscopy patients currently are asked to do) and an extended nothing-by-mouth period as potential new measures to reduce the risk of retained gastric contents for patients on GLP-1RA
Key takeaways Both Zepbound and Wegovy are effective weight loss medications, but Zepbound produces more weight loss than Wegovy, according to research